Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis
Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
- To assess the long term safety of Sarilumab (SAR153191/REGN88) in participants with
ankylosing spondylitis (AS)
Secondary Objective:
- To assess the long term efficacy of Sarilumab (SAR153191/REGN88) in participants with AS